TCL Archive Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients December 28, 2012
TCL Archive In Brief: ACS to support $2 Billion NCI Budget; NCAB Backs Minority Enhancement Core Supplements February 19, 1988